EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

DNMT Enzymes and Their Impact on Cervical Cancer: A State-of-the-Art Review

Eric Genaro Salmerón-Bárcenas, Andrea Martínez-Zayas, Miguel Vargas-Mejía iD, Nicolas Villegas-Sepúlveda iD, Paola Briseño-Díaz iD, Arturo Aguilar-Rojas iD, Christian Johana Baños-Hernández iD, Francisco Israel Torres-Rojas, Ramón Antaño-Arias iD, Rosaura Hernández-Rivas iD

International Journal of Molecular Sciences · 29.10.2025 · 26 (21) · 10496

DOI: 10.3390/ijms262110496 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 29.10.2025. Verfasst von Eric Genaro Salmerón-Bárcenas und 9 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Biomedicina Molecular, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Ciudad de Mexico 07360, Me…. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, DNA (Cytosine-5-)-Methyltransferases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 208 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genomic DNA methylation is an epigenetic modification that primarily occurs at CpG sites and is associated with the transcriptional repression of genes. This process plays a crucial role in maintaining cellular homeostasis and is catalyzed by a family of enzymes known as DNA methyltransferases (DNMTs), which includes DNMT1, DNMT2, DNMT3A, DNMT3B, and DNMT3L. DNMT1 is classified as a maintenance methyltransferase, whereas DNMT3A and DNMT3B are responsible for de novo methylation. Altered expression of DNMTs has been reported in various human diseases, including cancer. Cancer remains a major global health issue, with an estimated 20 million new cases and 9.7 million deaths reported in 2022. Among women, cervical cancer (CC) ranks fourth in both incidence and mortality worldwide, with persistent infection by high-risk human papillomavirus (HR-HPV) being the primary risk factor. Several studies have demonstrated that DNMT expression and activity are upregulated in CC, suggesting their potential as diagnostic and prognostic biomarkers. HR-HPV infection appears to increase DNMT expression, thereby promoting cervical carcinogenesis through aberrant methylation and subsequent silencing of tumor-suppressor genes such as PTEN, PAX1, and TSLC1. Furthermore, DNMTs are being explored as therapeutic targets in CC. In this review, we summarize the current state of the art regarding DNMTs in cervical cancer and discuss their functional roles and potential utility as diagnostic, prognostic, and therapeutic biomarkers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsDNA (Cytosine-5-)-MethyltransferasesHumansFemaleDNA MethylationGene Expression Regulation, NeoplasticEpigenesis, GeneticBiomarkers, TumorPapillomavirus InfectionsAnimals

Stichwörter der Autor:innen

5-mCDNMT1DNMT2DNMT3ADNMT3BDNMT3Lcervical cancermethylation

Substanzen

DNA (Cytosine-5-)-MethyltransferasesBiomarkers, Tumor

Autor:innen und Institutionen

  • Departamento de Biomedicina Molecular, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Ciudad de Mexico 07360, Mexico.
  • Departamento de Genética y Biología Molecular, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Ciudad de Mexico 07360, Mexico.
  • Unidad de Investigación Médica en Medicina Reproductiva, UMAE en Ginecología y Obstetricia No. 4, Instituto Mexicano del Seguro Social, Ciudad de Mexico 01070, Mexico.
  • Instituto de Investigación en Ciencias Biomédicas, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.
  • Laboratorio de Biomedicina Molecular, Facultad de Ciencias Químico Biológicas, Universidad Autónoma de Guerrero, Chilpancingo 39086, Mexico.

ORCID-Profile: Miguel Vargas-Mejía, Nicolas Villegas-Sepúlveda, Paola Briseño-Díaz, Arturo Aguilar-Rojas, Christian Johana Baños-Hernández, Ramón Antaño-Arias, Rosaura Hernández-Rivas

Zitieren

APA

Salmerón-Bárcenas, E. G., Martínez-Zayas, A., Vargas-Mejía, M., Villegas-Sepúlveda, N., Briseño-Díaz, P., Aguilar-Rojas, A., Baños-Hernández, C. J., Torres-Rojas, F. I., Antaño-Arias, R., & Hernández-Rivas, R. (2025). DNMT Enzymes and Their Impact on Cervical Cancer: A State-of-the-Art Review. International Journal of Molecular Sciences, 26(21), 10496. https://doi.org/10.3390/ijms262110496

Vancouver

Salmerón-Bárcenas EG, Martínez-Zayas A, Vargas-Mejía M, Villegas-Sepúlveda N, Briseño-Díaz P, Aguilar-Rojas A, et al. DNMT Enzymes and Their Impact on Cervical Cancer: A State-of-the-Art Review. International Journal of Molecular Sciences. 2025;26(21):10496. doi:10.3390/ijms262110496

BibTeX
@article{SalmernBrcenas2025,
  author = {Salmerón-Bárcenas, Eric Genaro and Martínez-Zayas, Andrea and Vargas-Mejía, Miguel and Villegas-Sepúlveda, Nicolas and Briseño-Díaz, Paola and Aguilar-Rojas, Arturo and Baños-Hernández, Christian Johana and Torres-Rojas, Francisco Israel and Antaño-Arias, Ramón and Hernández-Rivas, Rosaura},
  title = {DNMT Enzymes and Their Impact on Cervical Cancer: A State-of-the-Art Review},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {21},
  pages = {10496},
  doi = {10.3390/ijms262110496}
}
Kostenlos starten →